PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.09
ESG score 80-90% of EXEL's 65.64. Walter Schloss would scrutinize governance quality and regulatory exposure.
56.82
Environmental score 80-90% of EXEL's 63.14. Walter Schloss would scrutinize carbon exposure and transition planning.
57.54
Social score 80-90% of EXEL's 65.74. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
59.92
Governance score 80-90% of EXEL's 68.03. Walter Schloss would scrutinize management accountability and board independence.